Beyond the Biobucks
TERMINAL
CHINA → WEST LICENSING · PUBLIC SOURCES ONLY · DATA BUILT 2026-11-16
FIGURES PENDING REVIEW
AS OF
LATEST
DEALS ANNOUNCED
ANNOUNCED VALUE Σ
RISK-ADJUSTED Σ · MODEL
CONFIRMED PAID Σ
ENDED OR CUT BACK
Year: all
Company: all
Indication: all
Modality: all
Status: all
Active
Partly returned
Terminated
Stage: all
Preclinical
Phase 1
Phase 2
Phase 3
Filed
Approved
Area: all
Oncology
Other
Signed
Licensor
Licensee
Asset
Indication
Modality
Stage
Upfront
Announced Σ
Risk-adj.
Paid Σ
%
Status
Rev